Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma

Frontiers in Cell and Developmental Biology

Zhirong Li¹  Ren Niu²  Xuebo Qin³  Shujun Li⁴  Shaolin Gao⁴  Fangchao Zhao⁴  Chuan Wang⁵ 

[1] Clinical Laboratory Center, The Second Hospital of Hebei Medical University, Shijiazhuang, China;Department of Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China;Department of Thoracic Surgery, Hebei Chest Hospital, Shijiazhuang, China;Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China;The Second Hospital of Hebei Medical University, Shijiazhuang, China;

关键词: esophageal squamous cell carcinoma;    TRP channel-related genes;    prognostic signature;    immune microenvironment;    TCGA;   

DOI  :  10.3389/fcell.2022.820870

来源: DOAJ

【 摘 要 】

The Nobel Prize in Physiology or Medicine for the year 2021 was awarded to Ardem Patapoutian and David Julius for their discoveries of temperature-sensitive receptors (TRP channels) and tactile receptors (Piezo channels), both of which were previously unknown. TRP channels are at the heart of the human ability to detect temperature, and they also play crucial regulatory functions in the occurrence and progression of cancer. Despite this, there have been no research conducted on the prognostic significance of TRP channels in individuals with esophageal squamous cell carcinoma (ESCC). In GEO and TCGA cohorts, unsupervised clustering was first conducted based on 18 TRP channel-associated differentially expressed genes (DEGs) extracted from MSigDB database and KEGG database. Two TRP subtypes were identified and patients in subtype B had the best prognosis among the two subtypes. Significant differences in staging and grading existed among the different subtypes. In GEO cohort, univariate Cox analysis were performed to screen prognosis related genes. A TRP channel-related prognostic signature, which included 7 signature-related genes, was constructed by the least absolute shrinkage and selection operator (LASSO) Cox regression. Patients were divided into a high-risk group and low-risk group by the median risk score. In GEO and TCGA cohorts, Receiver operating characteristic (ROC) curves, principal component analysis (PCA), and univariate and multivariate Cox regression were performed to confirm the validity of signature. Following a more in-depth study of the TME based on the risk signature, it was discovered that the high-risk group had higher immune cell infiltration and lower tumor purity, indicating a bad prognosis. Patients with high risk scores also had increased immune checkpoint expression, indicating that these patients may be more likely to benefit from immunotherapy than other patients. We also found that paclitaxel, cisplatin, and 5-fluorouracil displayed a better response in treating the low-risk score ESCC patients. This study also adopted GTEx and qRT-PCR to perform experimental verification processes. In summary, we identified a TRP channel-associated prognostic signature. This signature can predict prognosis and immune microenvironment in ESCC.

【 授权许可】

Unknown